{
  "meta": {
    "timestamp": "2025-01-06T12:37:17.361488",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Sophia Genetics SA",
      "symbol": "SOPH",
      "analysis": {
        "historical": {
          "risk_score": 50,
          "key_risks": [
            "Data Privacy and Security: Handling sensitive genomic data requires stringent compliance with global data protection regulations.",
            "Regulatory Compliance: Operating in a highly regulated industry with diverse healthcare standards across jurisdictions.",
            "Market Competition: Intense competition in the genomics and AI-driven healthcare sectors.",
            "Financial Performance: Scrutiny over consistent financial performance and path to profitability as a new public company."
          ],
          "controversies": [
            "Data Privacy and Security: Potential legal repercussions and loss of trust if data privacy measures fail.",
            "Regulatory Compliance: Possible delays in product approvals or market access due to regulatory hurdles."
          ],
          "environmental_issues": [],
          "social_issues": [
            "Data Privacy: Ensuring the ethical handling of sensitive genomic data to protect patient privacy."
          ],
          "governance_issues": [
            "Regulatory Compliance: Adherence to diverse healthcare standards and regulations across multiple jurisdictions."
          ],
          "recommendation": "caution",
          "confidence_score": 75
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Privacy Policy - SOPHiA GENETICS",
              "snippet": "SOPHiA GENETICS values the privacy of the website's users and the confidentiality of their data. That is why SOPHiA GENETICS is committed to treating your Personal Data with care, integrity, and transparency. SOPHiA GENETICS SA, which is headquartered at La Piece, 12, CH-1180",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442772+00:00",
              "published_date": null,
              "source_hash": "5bee6573fe289ff0250ea89c5b864980"
            },
            {
              "url": "",
              "title": "EXCLUSIVE LICENCE OF PATENTS AND RESULTS by SOPHiA GENETICS SA | Law ...",
              "snippet": "Certain confidential information contained in this document, marked by [**], has been omitted because SOPHiA GENETICS SA (SOPHiA) has determined that the information (i) is not material and (ii) is the type that SOPHiA customarily and actually treats as private or confidential.. Exhibit 10.2 . EXCLUSIVE LICENCE OF PATENTS AND RESULTS",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442821+00:00",
              "published_date": null,
              "source_hash": "4e024de3e0aa11482417202c4f08cb2a"
            },
            {
              "url": "",
              "title": "Investor Relations | SOPHiA GENETICS, Inc. - Resources",
              "snippet": "SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. SOPHiA DDM\u2122 Dx Hereditary Cancer Solution, SOPHiA DDM\u2122 Dx RNAtarget Oncology Solution and SOPHiA DDM\u2122 Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in Europe and Turkey.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442833+00:00",
              "published_date": null,
              "source_hash": "530b66d8429a6badc3ba86a8fadb0b2f"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS SA (SOPH): A Bull Case Theory - Yahoo Finance",
              "snippet": "We came across a bullish thesis on SOPHiA GENETICS SA (SOPH) on Two Natural Cap's Substack by Two Natural Capital. In this article, we will summarize the bulls' thesis on SOPH. SOPHiA GENETICS ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442846+00:00",
              "published_date": null,
              "source_hash": "eba232129ccda804cbc29bc8a45f2f3c"
            },
            {
              "url": "",
              "title": "Sophia Genetics SA - Company Profile - GlobalData",
              "snippet": "Sophia Genetics company overview and more information Sophia Genetics SA (Sophia Genetics) is a provider of health technological solutions such as SOPHiA Artificial Intelligence for clinical genomics and next-generation sequencing (NGS) data analysis. The company also provides dry lab, bundle solutions and integrated diagnostic solutions.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370451+00:00",
              "published_date": null,
              "source_hash": "c6ba736695196fe2b19bba2530165d81"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "Consolidated Financial Statements of SOPHiA GENETICS SA for the Year ended December 31, 2023 106 Report of the Statutory Auditor on the Statutory Financial Statements of ... different therapy decisions in addition to allowing clinicians to perform patient cohorting and data visualization. Leveraging SOPHiA DDM\u2122 to provide value to our ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442863+00:00",
              "published_date": null,
              "source_hash": "99b6aeb6b4633cd4ae6702392b4a6234"
            },
            {
              "url": "",
              "title": "Sophia Genetics' new technology for genomic data privacy means secure ...",
              "snippet": "LAUSANNE, Switzerland - 06 December 2016: Sophia Genetics, global leader in Data-Driven Medicine, unveiled today a new privacy-protecting technology for the storage and access to patients' genomic information worldwide, paving the way to a new industry standard. The largest clinical genomics platform - 215 hospitals from 35 countries ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442873+00:00",
              "published_date": null,
              "source_hash": "160a14d16cddb2cc731c55abeb9f49b9"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS - Crunchbase Company Profile & Funding",
              "snippet": "SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM\u2122 Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442880+00:00",
              "published_date": null,
              "source_hash": "da505b2aca1d46447774e5f7f3d3f09a"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS - Overview, News & Similar companies - ZoomInfo",
              "snippet": "SOPHiA GENETICS is a data-driven medicine company that uses statistical inference, pattern recognition and machine learning for genomics and radiom ics data to support the healthcare industry. SOPHiA GENETICS, headquartered in Saint-Sulpice, Switzerland, is used by geneticists, pathologists and radiologists in hospitals. Read more",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442890+00:00",
              "published_date": null,
              "source_hash": "1bc2294cdcb38324ac18e7a5f394b2a8"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS SA (SOPH) Company Profile & Overview - Stock Analysis",
              "snippet": "SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:49.442898+00:00",
              "published_date": null,
              "source_hash": "e779b06d72e5049be4f5ff674ee08557"
            },
            {
              "url": "",
              "title": "Principal Financial Group Inc. Raises Position in SOPHiA GENETICS SA (NASDAQ:SOPH)",
              "snippet": "SOPHiA GENETICS SA has a 12-month low of $2.70 and a 12-month high of $7.37. The firm has a fifty day moving average price of $3.38 and a 200-day moving average price of $3.80.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:37:01.748385+00:00",
              "published_date": "2025-01-02T00:00:00+00:00",
              "source_hash": "019b10f57d295f1932fa4e9eed5afde9"
            },
            {
              "url": "",
              "title": "Morgan Stanley Sticks to Its Hold Rating for SOPHiA GENETICS (SOPH)",
              "snippet": "SOPHiA GENETICS (SOPH) Company Description: Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:52.796525+00:00",
              "published_date": "2024-11-19T07:36:00+00:00",
              "source_hash": "0d923442ec709f77750b828f5c29d7af"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer",
              "snippet": "BOSTON and LAUSANNE, Switzerland, Jan. 26, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that democratizes data ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA data privacy lawsuits",
              "retrieved_at": "2025-01-06T19:36:52.796558+00:00",
              "published_date": "2022-01-26T14:38:00+00:00",
              "source_hash": "1f859dafdc06343391f916b3392c735d"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS Transforms Quality Management to Ensure Compliance and ...",
              "snippet": "SOPHiA GENETICS, a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. But significant growth presented SOPHiA GENETICS with the challenge of establishing a quality management system that could help it optimize efficiency and ensure regulatory compliance as it scaled. COMPANY - AT A",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633695+00:00",
              "published_date": null,
              "source_hash": "86b24e8adef7358209414f8ac10eb7e6"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "SOPHiA GENETICS SA was incorporated as a Swiss stock corporation (soci\u00e9t\u00e9 anonyme) under the laws of Switzerland on March 18, 2011. Our principal executive office is located at La Pi\u00e8ce 12, CH-1180 Rolle, Switzerland and our telephone number is +41 21 694 10 60. Our agent for service of",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633777+00:00",
              "published_date": null,
              "source_hash": "a1d33008c1ff187f8cca604760488dcb"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS Publishes Environmental, Social and Governance Impact ...",
              "snippet": "BOSTON, United States and LAUSANNE, Switzerland, June 15, 2022 \u2014 SOPHiA GENETICS SA (Nasdaq: SOPH) (\"the Company\"), today announced that the Company has published its first Environmental, Social and Governance Impact Summary (\"ESG Impact Summary\"). The ESG Impact Summary highlights the Company's policies, ongoing practices, and recent initiatives across a range of areas including ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370397+00:00",
              "published_date": null,
              "source_hash": "b292e5fcef24de49f165f0c9e47e9f13"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "SOPHiA GENETICS SA _____ Approved by the Board of Directors on June 29, 2021 ... (iv) the Company's compliance with legal and regulatory requirements; and (b) prepare the Committee report that the Securities and Exchange Commission (the \"SEC\") ... of any issues that arise with respect to the quality or integrity of the Company's finan-cial ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633810+00:00",
              "published_date": null,
              "source_hash": "d83b3f88c99b0543f3a460538924c94b"
            },
            {
              "url": "",
              "title": "PESTEL Analysis of SOPHiA GENETICS SA (SOPH) - DCF, SWOT, CANVAS ...",
              "snippet": "In today's rapidly evolving landscape, understanding the myriad factors influencing a company's operations is essential. For SOPHiA GENETICS SA (SOPH), a leader in data-driven medicine, a comprehensive PESTLE analysis reveals critical insights into its business environment.From navigating regulatory compliance to harnessing technological advancements, each element plays a pivotal role in ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633820+00:00",
              "published_date": null,
              "source_hash": "15832236fadf83099de5a5b083bf4695"
            },
            {
              "url": "",
              "title": "Investor Relations | SOPHiA GENETICS, Inc. - Resources",
              "snippet": "SOPHiA Genetics SA was incorporated in Switzerland in 2011. ... SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. ... may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at support ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633829+00:00",
              "published_date": null,
              "source_hash": "9a32c497a64e44a6a921bb778c761056"
            },
            {
              "url": "",
              "title": "SOPHiA DDM\u2122 Platform Certified Under IVDR - SOPHiA GENETICS",
              "snippet": "Regulatory milestone validates the SOPHiA DDM\u2122 Platform as diagnostic tool in select markets. Boston, US and Rolle, Switzerland, August 14, 2024 - SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that its SOPHiA DDM\u2122 Platform is now CE marked under the European Union's In Vitro Diagnostic ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633838+00:00",
              "published_date": null,
              "source_hash": "1247e818a7a95ed0509f8238bf78a22b"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS Publishes Environmental, Social and Governance Impact ...",
              "snippet": "BOSTON and LAUSANNE, Switzerland, June 15, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) (\"the Company\"), today announced that the Company has published its first Environmental, Social ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633848+00:00",
              "published_date": null,
              "source_hash": "fe12db0e2d76c8c2cfdca118694383ce"
            },
            {
              "url": "",
              "title": "PDF",
              "snippet": "compliance organization, in order to ensure that SOPHiA GENETICS SA and, as applicable, its subsidiaries comply with applicable U.S., Swiss, and international laws and regulations. This Code is not exhaustive, and its content may be updated from time to time. Next to this Code of Business Conduct, please also",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633857+00:00",
              "published_date": null,
              "source_hash": "bdeec38e9b8a2108fd16057c92c4181d"
            },
            {
              "url": "",
              "title": "Investor Relations | SOPHiA GENETICS, Inc. - News",
              "snippet": "SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 Guidance Sep 9, 2021. PDF Version. BOSTON and LAUSANNE, Switzerland, Sept 9, 2021 \u2014 SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021. ... Co-Founder and CEO of SOPHiA GENETICS. \"I am encouraged by our ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:54.633866+00:00",
              "published_date": null,
              "source_hash": "93d4aa3b0d55715785f5ab1bfdfb4064"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS SA",
              "snippet": "SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:37:01.748515+00:00",
              "published_date": "2021-09-04T15:29:00+00:00",
              "source_hash": "7a09695c92fc79d060cecbf52aa4db67"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer",
              "snippet": "BOSTON and LAUSANNE, Switzerland, Jan. 26, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq ... or market clearance by a governmental regulatory body for different indications for use.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:57.764645+00:00",
              "published_date": "2022-01-26T14:38:00+00:00",
              "source_hash": "57596145538bcbf1ca513caea9276413"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS SA (SOPH)",
              "snippet": "IVDR certification is a significant regulatory milestone that validates ... 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a healthcare technology company and a leader in data-driven ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:57.764670+00:00",
              "published_date": "2024-12-06T00:01:00+00:00",
              "source_hash": "b28c902ea80bd866a9193190bc731993"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS and Genomenon Collaborate to Streamline Genetic Research",
              "snippet": "BOSTON and ROLLE, Switzerland, Nov. 6, 2024 /PRNewswire-PRWeb/ -- SOPHiA GENETICS (Nasdaq ... approval or market clearance by a governmental regulatory body for different indications for use.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Sophia Genetics SA Sophia Genetics SA regulatory compliance issues",
              "retrieved_at": "2025-01-06T19:36:57.764693+00:00",
              "published_date": "2024-11-25T06:46:00+00:00",
              "source_hash": "b3cdcb23e973f2cc9421fc58fb41b06f"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS Publishes Environmental, Social and Governance Impact ...",
              "snippet": "SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research.It is the ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370422+00:00",
              "published_date": null,
              "source_hash": "608c9c1a36cf97f9bab2ec48f4ae0d5f"
            },
            {
              "url": "",
              "title": "PESTEL Analysis of SOPHiA GENETICS SA (SOPH) - DCF, SWOT, CANVAS ...",
              "snippet": "SOPHiA GENETICS SA (SOPH) - PESTLE Analysis: Social factors Sociological. Increasing public awareness of genetic testing benefits: The global genetic testing market was valued at approximately $13.3 billion in 2023 and is projected to reach $27.7 billion by 2030, growing at a CAGR of 11.2%. This surge is largely attributed to rising public awareness of the benefits associated with genetic ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370429+00:00",
              "published_date": null,
              "source_hash": "3b62f819f67bf93f641adb82093c48d2"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS - Where others see data we see answers",
              "snippet": "Retain ownership of your data. SOPHiA DDM\u2122: A universal healthcare analytics platform. Powered by AI and machine learning (ML), our global cloud-based platform provides a safe, secure, and instantly accessible environment to standardize, compute, and analyze digital health data, generating insights from complex multimodal data sets that have the potential to improve diagnosis, therapy ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370435+00:00",
              "published_date": null,
              "source_hash": "73dc67b9cd41b9cfcfe0a62f72896434"
            },
            {
              "url": "",
              "title": "Sophia Genetics - Wikipedia",
              "snippet": "Sophia Genetics SA is a data-driven medicine software company with headquarters in Lausanne, Switzerland and Boston, Massachusetts. [2] [3] ... In 2019, Sophia Genetics formed partnerships with Integrated DNA Technologies and Paragon Genomics, next-generation sequencing (NGS) assay development company, ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370441+00:00",
              "published_date": null,
              "source_hash": "14cae59882a412696b8d6769c0d5e39c"
            },
            {
              "url": "",
              "title": "Sophia Genetics SA - Venturelab",
              "snippet": "Sophia Genetics SA: As the global leader in Data-Driven Medicine, SOPHiA GENETICS helps healthcare professionals better diagnose and treat cancers and hereditary disorders thanks to complex genomics and radiomics analysis powered by SOPHiA AI. The company achieves its mission of contributing to a mo...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370446+00:00",
              "published_date": null,
              "source_hash": "6752120402c96f3cfc88e938105f0bf1"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS - Overview, News & Similar companies - ZoomInfo",
              "snippet": "SOPHiA GENETICS is a data-driven medicine company that uses statistical inference, pattern recognition and machine learning for genomics and radiom ics data to support the healthcare industry. SOPHiA GENETICS, headquartered in Saint-Sulpice, Switzerland, is used by geneticists, pathologists and radiologists in hospitals. ... SOPHiA GENETICS SA ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370456+00:00",
              "published_date": null,
              "source_hash": "f594d616fa3c7a4119f39c018813190a"
            },
            {
              "url": "",
              "title": "Mission Statement, Vision, & Core Values (2024) of SOPHiA GENETICS SA ...",
              "snippet": "[relinking] Home Overview Mission Vision Values An Overview of SOPHiA GENETICS SA (SOPH) General Summary of SOPHiA GENETICS SA SOPHiA GENETICS SA is a cloud-native software company based in Rolle, Switzerland, founded on March 18, 2011. The company is focused on advancing data-driven medicine through its proprietary platform, the SOPHiA DDM TM, which facilitates the analysis of complex ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370460+00:00",
              "published_date": null,
              "source_hash": "13e9d373de82cbb16360eae7ebb85309"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS Publishes Environmental, Social and Governance Impact ...",
              "snippet": "BOSTON and LAUSANNE, Switzerland, June 15, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (Nasdaq: SOPH) (\"the Company\"), today announced that the Company has published its first Environmental, Social and Governance Impact Summary (\"ESG Impact Summary\"). The ESG Impact Summary highlights the Company's policies, ongoing practices, and recent initiatives across a range of areas including innovation and ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:36:59.370465+00:00",
              "published_date": null,
              "source_hash": "4290194f173d84250f2421bfe0f6574f"
            },
            {
              "url": "",
              "title": "Sophia Genetics unveils latest 'genome browser' software",
              "snippet": "The Swiss medical data firm Sophia Genetics has launched the latest iteration of its \"genome browser\" software, which uses artificial intelligence (AI) to help researchers assess whether ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:37:01.748486+00:00",
              "published_date": "2018-10-18T00:00:00+00:00",
              "source_hash": "80ab567424c5411cd34d436ba37f7396"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS's SWOT analysis: biopharma firm navigates headwinds, eyes growth",
              "snippet": "SOPHiA GENETICS SA (NASDAQ ... SOPHiA GENETICS specializes in providing data-driven solutions for the healthcare industry, particularly in the field of genomics and personalized medicine.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:37:01.748539+00:00",
              "published_date": "2024-12-13T10:37:00+00:00",
              "source_hash": "b979bcb243b4a4564b6e50dc82d87c63"
            },
            {
              "url": "",
              "title": "SOPHiA GENETICS Announces L'h\u00f4pital Universitaire Avicenne is Live on SOPHiA DDM\u2122",
              "snippet": "BOSTON and ROLLE, Switzerland, July 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq ... which analyzes complex genomic and multimodal data and generates real-time, actionable insights for ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Sophia Genetics SA Sophia Genetics SA ethical concerns genomic data usage",
              "retrieved_at": "2025-01-06T19:37:01.748563+00:00",
              "published_date": "2024-11-13T00:00:00+00:00",
              "source_hash": "eaf69e0d21b8847b38499e9dd86c36d7"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Sophia Genetics SA data privacy lawsuits",
              "rationale": "Investigate legal challenges related to data privacy and security",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Sophia Genetics SA regulatory compliance issues",
              "rationale": "Examine compliance with healthcare and data privacy regulations across different regions",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Sophia Genetics SA ethical concerns genomic data usage",
              "rationale": "Explore ethical implications of handling and analyzing sensitive genomic data",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T12:37:17.361496",
        "data_confidence": 75,
        "pattern_confidence": null
      }
    }
  ]
}